Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru

BACKGROUND: Despite the advances in the management of advanced non–small cell lung cancer (NSCLC), the access to genetic profiling and target therapies remains a challenge in Latin America, even in countries with a higher rate of targetable mutations. The aim of this study is to evaluate the clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvez‐Nino, Marco, Ruiz, Rossana, Roque, Katia, Coanqui, Ofelia, Valdivieso, Natalia, Olivera, Mivael, Ganti, Apar Kishor, Mas, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807447/
https://www.ncbi.nlm.nih.gov/pubmed/36369763
http://dx.doi.org/10.1111/1759-7714.14714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807447/
https://www.ncbi.nlm.nih.gov/pubmed/36369763
http://dx.doi.org/10.1111/1759-7714.14714

Ejemplares similares